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Abstract The sodium/proton exchanger protein 3 (NHE3) is
located in chemosensitive areas of the medulla oblongata and
plays an important role in the central control of respiration.
Overexpression of NHE3 is correlated with lower respiration
and might therefore contribute to the vulnerability of infants
dying suddenly and unexpected (sudden infant death syn-
drome, SIDS). Our aim in this study was to verify already
reported genetic variations in the NHE3 gene in an indepen-
dent SIDS cohort from Switzerland. Two single nucleotide
polymorphisms (SNPs) in the promoter region (G1131A and
C1197T) and one variation in the coding sequence of exon 16
(C2405T) in the NHE3 gene were analyzed in 160 Caucasian
SIDS infants and 192 Swiss adult controls by using a single
base extension method (SNaPshot multiplex). No significant
differences were detected in the allelic frequencies of the three
NHE3 polymorphisms between SIDS cases and controls. We
conclude that the three investigated NHE3 SNPs are unlikely
to play a major role in the pathogenesis of SIDS in Caucasian
infants. However, further genetic investigations in different
ethnicities are required to determine whether variations in
NHE3 are associated with an increased SIDS risk.
Keywords Sudden infant death syndrome . Genetic risk
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Introduction
Sudden infant death syndrome (SIDS) is defined as the sudden
and unexpected death of an apparently healthy infant younger
than 1 year of age [1]. The identification and prevention of
several environmental risk factors, such as the prone sleeping
position, sharing bed with parents, or exposure to smoking,
have contributed to a drastic reduction of SIDS cases in the
last 20 years [2–4]; however, SIDS is still the leading cause of
postneonatal infant death in developed countries [5]. Today,
the pathogenesis of SIDS is widely accepted as a multifacto-
rial disorder that involves a critical developmental period in
combination with environmental and genetic risk factors [6].
The most important genetic risk factors with respect to SIDS
are variants in genes leading to a dysfunctional immune
system response, defects in the autonomic regulation of car-
diovascular activities, and respiratory failures [7–9].
The control of autonomic respiration is located in the
medulla oblongata where a change in CO2/H
+ is sensed by
specialized central chemosensitive neurons [10]. Elevation of
CO2/H
+ levels increases the firing rate of these brainstem
neurons, which is mediated by an increase of intracellular free
protons and increased respiration. To maintain the acid-base
balance, an electroneutral exchange of Na+ for H+ is accom-
plished by transmembrane sodium/proton exchangers (NHE)
[11]. NHEs exist in at least nine different isoforms in humans,
whereas all isoforms have tissue-specific distributions [12].
Inhibition of the subtype sodium/proton exchanger 3 (NHE3,
also known as SLC9A3) resulted in a lower apneic threshold
and an increased respiration in rabbits, demonstrating that this
NHE isoform is involved in the central respiratory response
[13]. Additionally, the level of NHE3 mRNAwas found to be
inversely correlated to the degree of respiratory drive, mean-
ing high ventilation is correlated with low NHE3 expression
levels and vice versa [14]. It was supposed that an overex-
pression of NHE3 leading to lower ventilation may predispose
individuals to central apnea and sleep-disordered breathing
and might therefore also contribute to the vulnerability of
SIDS infants [15]. Genetic investigations of the NHE3 gene
in German SIDS infants revealed three variants that were
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significantly more frequent in SIDS infants than in control
subjects [16]. Two of these single nucleotide polymorphisms
(SNPs) are located in the promoter region of the NHE3 gene
(G1131A and C1197T) and the third SNP is located on exon
16 (C2405T). Since these findings have not been replicated in
an independent SIDS cohort, our aims were to investigate the
three NHE3 polymorphisms in a SIDS cohort from Switzer-
land and to verify these variants as possible predisposing
factors in the occurrence of SIDS.
Material and methods
Study population
Our study population was composed of 160 SIDS cases
and initially 532 adult controls. All SIDS cases were
collected between 1985 and 2012 at the Institute of
Legal Medicine in Zurich, Switzerland, whereas most
of them were examined by the same forensic patholo-
gist. Since 2004, SIDS cases were classified according
to the San Diego definition, which includes a complete
autopsy, review of the circumstances of death, and ex-
amination of the clinical history [1]. 40 (23 males/17
females) SIDS cases out of the 160 infants were deter-
mined as genuine SIDS cases belonging to category I
with a normal clinical history and no assigned cause of
death. The remaining 120 (72 males/48 females) SIDS
infants were categorized in category II due to slight
infections prior to death, preterm birth, or other devia-
tions to category I requirements. According to the au-
topsy records, all SIDS infants were Caucasian and
most of them had parents with Swiss origin. The total
SIDS cohort was composed of 95 males and 65 females
and the median age was 14.9±10.4 weeks (range 0.6–
48.1 weeks). Information about environmental risk fac-
tors such as the prone sleeping position or exposure to
parental smoking behavior was available from the au-
topsy reports of most infants.
The initial control population was composed of 532
healthy Caucasian adults (228 females/304 males). How-
ever, genetic investigations of the three NHE3 SNPs
showed that the allelic distribution of these SNPs devi-
ated from the Hardy-Weinberg equilibrium (HWE). As-
suming that this may be an indicator for population
heterogeneity [17], the statistical analysis was only per-
formed with those adults that reported Swiss descent
(n=192; 77 females/115 males).
Ethical approval for this study was provided by the local
ethics committee in Zurich (KEK-ZH-Nr. 2013-0086), and the
study was conducted in full conformance with Swiss laws and
regulations.
DNA extraction and quantification
Genomic DNA of SIDS infants was obtained from tissues
stored in alcohol or from alcohol-fixed paraffin-embedded
tissue blocks [18]. Most of the tissues were kidney or tongue
(otherwise heart, muscle, or brain) because of reported good
postmortem DNA stability in these tissues [19]. DNA extrac-
tions were performed using the QIAamp DNA Mini Kit
(Qiagen, Hombrechtikon, Switzerland) according to the man-
ufacturer’s protocol. DNA of the adult controls was extracted
from blood [20] or buccal swabs [21]. All DNA quantities
were determined with the QuantifilerTM Human DNA quan-
tification kit (Life Technologies, Rotkreuz, Switzerland).
SNP analysis
Multiplex PCR amplification was performed with 1 ng DNA
as a template using the QIAGENMultiplex PCR Kit (Qiagen)
according to the manufacturer’s protocol in a total volume of
15 μl and with the same PCR primer sequences as described
by Poetsch et al. [16]. Primer concentrations were 0.1 μM for
C2405T, 0.05 μM for G1131A, and 0.1 μM for C1197T.
Thermal cycling conditions were as follows: initial incubation
at 95 °C for 15 min, followed by 35 cycles of 94 °C for 30 s,
57–64 °C for 90 s (increase of 0.2 °C per cycle), 72 °C for
60 s, and a final extension at 72 °C for 60 min. The three SNP
variations (C2405T, G1131A, and C1197T) were then geno-
typed in a multiplex reaction by using a single base extension
(SBE) method with the SNaPshot multiplex kit (Life Tech-
nologies) according to the manufacturer’s protocol. SBE
primer sequences were the same as described by Poetsch
et al. [16]. Primer concentrations were 1 μM for C2405T,
0.05 μM for G1131A, and 0.2 μM for C1197T. Thermal
cycling conditions were as follows: rapid thermal ramp to
96 °C followed by 25 cycles of 96 °C for 10 s, 50 °C for
5 s, and 60 °C for 30 s. SBE products were detected by
capillary electrophoresis on a 3130xl Genetic Analyzer (Life
Technologies) and analyzed with the GeneMapper ID-X 1.2
software (Life Technologies). Inconclusive results were re-
peated at least once.
Statistical analysis
Data analysis was performed with the statistical software IBM
SPSS version 20 (SPSS Inc., Chicago, USA). The HWE was
calculated with a web-based HWE calculator software [22]. A
χ2 value of ≥3.84 indicated a deviation of the HWE at a
significance level of 0.05. Differences of the genetic investi-
gations between SIDS and controls were compared by a
Pearson χ2 test in a 2×2 table for allelic frequencies and in a
3×2 table for genotypes. A p value ≤0.05 was considered
statistically significant. All reported p values are two-sided.
940 Int J Legal Med (2014) 128:939–943
Results and discussion
In our study population of 160 Caucasian SIDS cases and 192
Swiss adult controls, we found no differences in the allelic
distribution of the three investigated NHE3 SNPs C2405T,
G1131A, and C1197T between SIDS cases and controls
(C2405T: p value=0.376; G1131A: p value=0.578;
C1197T: p value=0.460) (Table 1). The homozygous TT
genotype of C2405T and the homozygous AA genotype of
G1131Awere found only rarely in SIDS cases (1.5 and 1.9 %,
respectively) and controls (1.0 and 1.6 %, respectively). The
homozygous TT genotype of C1197T was neither found in
SIDS cases nor in the control population. HWE expectations
were met for all three SNPs (C2405T, G1131A, and C1197T)
in the SIDS group and the Swiss controls. SIDS group I
(n=40) and SIDS group II (n=120) were separately compared
to the control population, but no significant differences in the
allelic distribution of the three NHE3 polymorphisms were
detected in the two SIDS groups (data not shown).
Furthermore, the allelic distributions were similar between
female and male SIDS infants and between infants that died in
the months of highest SIDS risk (2–4 months) versus all other
months (data not shown). Infants found dead in the prone
sleeping position were further compared to infants in the
non-prone sleeping position, as sleeping on the stomachmight
be an external trigger for decreased breathing drive. Informa-
tion on sleeping position of SIDS infants was available in 94
cases, 64 cases of which were found dead in the prone
sleeping position. However, the allelic frequencies of
C2405T, G1131A, and C1197T were similarly distributed in
infants found dead in the prone position versus the non-prone
position (data not shown).
The C2405T is located on exon 16 and results in an amino
acid change from arginine (Arg) to cysteine (Cys) in the distal
region of the COOH terminal. This domain is regulated by the
binding of phosphatase 2A (PPA2), NHE regulating factor 1
(NHERF1), andmegalin (LRP2), which were shown to inhibit
NHE3 expression [23, 24]. Poetsch et al. hypothesized that a
change in the amino acid structure at this position may prevent
the binding of such expression regulating factors and thus
leading to an overexpression of NHE3 [16]. The two other
variations, G1131A and C1197T, are both located in the
promoter region where they may alter the promoter activity
of NHE3. In our study population, the homozygous TT geno-
type of C2405T was found in 1.5 % of all SIDS cases, the
homozygous AA genotype of G1131A in 1.9 % of all SIDS
cases, and the homozygous TT genotype of C1197T was not
observed in any SIDS case. Therefore, it seems rather unlikely
that these variations play a pathogenic role in the occurrence
of SIDS in Caucasian infants.
Our results are in contrast to the previously published
findings in 251 German SIDS infants and 220 controls, which
were composed of 170 adult controls and 50 infant controls
younger than 1 year of age [16]. We believe that infant
controls less than 1 year of age do not represent an optimal
control population, as the occurrence of SIDS cannot be
excluded in those infants. Under the assumption that SNP
genotypes are not affected by age, controls should be
gender- but not age-matched to the SIDS cohort [25].
This is our fourth study trying to verify previously de-
scribed genetic risk factors in an independent SIDS population
from Switzerland. As in this study, we could not confirm
significant associations between SIDS and polymorphisms
in the regulatory region of the serotonin transporter (5-HTT)
gene [26–28], in the tyrosine hydroxylase marker (TH01)
[29, 30], (Studer J., Bartsch C., and Haas C. Tyrosine
hydroxylase TH01 9.3 allele in the occurrence of sudden
infant death syndrome (SIDS) in Swiss Caucasians, accepted
for publication) and in the aquaporin-4 (AQP4) gene [31].
Such inconsistent results were also reported in other SIDS
association studies, e.g., in regard to polymorphisms in the
monoamine oxidase A (MAOA) or in serotonin (5-HTT)
pathway genes [32–37], (Studer J., Bartsch C., and Haas C.
Aquaporin-4 polymorphisms and brain/body weight ratio in
sudden infant death syndrome (SIDS) accepted for publica-
tion). A meta-analysis of 370 association studies demonstrat-
ed that first studies often suggest a stronger genetic effect
than is found by subsequent studies [38], which might be
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Table 1 Genotypes and allelic
distributions of NHE3 SNPs in
SIDS infants compared to
controls
Genotypes
[Number (%)]
Alleles
[Number (%)]
p value
C2405T CC CT TT C T
SIDS (n=160) 118 (73.5) 40 (25) 2 (1.5) 276 (86.2) 44 (13.8) 0.376
Controls (n=192) 132 (68.8) 58 (30.2) 2 (1.0) 322 (83.9) 62 (16.1)
G1131A GG GA AA G A
SIDS (n=160) 113 (70.6) 44 (27.5) 3 (1.9) 270 (84.4) 50 (15.6) 0.578
Controls (n=192) 129 (67.2) 60 (31.2) 3 (1.6) 318 (82.8) 66 (17.2)
C1197T CC CT TT C T
SIDS (n=160) 158 (98.8) 2 (1.2) 0 (0) 318 (99.4) 2 (0.6) 0.460
Controls (n=192) 191 (99.5) 1 (0.2) 0 (0) 383 (99.7) 1 (0.3)
one possible explanation for the conflicting results of these
replication studies. It is further recommended to perform
HWE tests in association studies, as significant differences
between the observed and expected genotype frequencies
under HWE may indicate genotyping errors or population
stratification and can inflate the chance of a false-positive
association [39, 40]. Even small amounts of population
admixture can shift the results toward an association, and
therefore, it is important to have a well-defined control
population in regard to ethnic and geographic background
[41]. Additionally, the well-known genetic heterogeneity of
SIDS cases and small sample sizes can contribute to the
different outcomes in SIDS association studies.
Conclusion
Although we could not confirm that the three NHE3 polymor-
phisms may be predisposing risk factors in the occurrence of
SIDS in Caucasian infants, NHE3 still remains of interest due
to its involvement in determining the set point of normal
breathing. Therefore, further genetic investigations of the
NHE3 promoter region and coding sequences should be per-
formed, also in other ethnical SIDS cohorts. Additionally,
gene expression studies are required to confirm the hypothesis
that the NHE3 mRNA is overexpressed in the brainstem of
SIDS infants.
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